Clonal haematopoiesis and cardiovascular diseases: challenges and opportunities | Clonal haematopoiesis of indeterminate potential (CHIP) has increasingly been recognized as a major non-traditional risk factor for cardiovascular disease (CVD). CHIP arises when haematopoietic stem cells acquire somatic mutations—most commonly in DNMT3A, …

Steven Haynes
0 Min Read
Share This Article
Leave a review

Leave a Review

Your email address will not be published. Required fields are marked *